Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Susceptibility of growth factors to degradation by Helicobacter pylori protease: effect of ebrotidine and sucralfate.

Slomiany BL, Piotrowski J, Slomiany A.

Biochem Mol Biol Int. 1996 Sep;40(1):209-15.

PMID:
8886287
2.

Suppression of Helicobacter pylori protease activity towards growth factors by sulglycotide.

Piotrowski J, Slomiany A, Slomiany BL.

J Physiol Pharmacol. 1997 Sep;48(3):345-51.

PMID:
9376617
3.

Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.

Piotrowski J, Piotrowski E, Slomiany A, Slomiany BL.

J Physiol Pharmacol. 1995 Dec;46(4):463-9.

PMID:
8770790
4.

Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.

Slomiany BL, Piotrowski J, Slomiany A.

Arzneimittelforschung. 1997 Apr;47(4A):475-82. Review.

PMID:
9205747
5.

Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.

Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1993 Aug;30(6):1127-34.

PMID:
8106073
6.

Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.

Slomiany BL, Piotrowski J, Mojtahed H, Slomiany A.

Gen Pharmacol. 1992 Mar;23(2):203-6.

PMID:
1639232
7.

Inhibition of Helicobacter pylori urease activity by ebrotidine.

Piotrowski J, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1995 Oct;37(2):247-53.

PMID:
8673007
8.

Suppression of Helicobacter pylori urease activity by sucralfate and sulglycotide.

Slomiany BL, Piotrowski J, Slomiany A.

Biochem Mol Biol Int. 1997 Jun;42(1):155-61.

PMID:
9192095
9.

In vitro anti-Helicobacter pylori activity of ebrotidine.

Palacín C, Tarragó C, Sacristán A, Ortiz JA.

Arzneimittelforschung. 1997 Apr;47(4A):471-4.

PMID:
9205746
10.

Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.

Slomiany BL, Piotrowski J, Slomiany A.

Am J Gastroenterol. 1992 May;87(5):595-9.

PMID:
1595646
11.

Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.

Slomiany BL, Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A.

Am J Gastroenterol. 1994 Jun;89(6):894-7.

PMID:
8198101
12.

Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.

Slomiany BL, Piotrowski J, Slomiany A.

J Physiol Pharmacol. 1999 Sep;50(3):391-404.

PMID:
10574469
13.

Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.

Slomiany BL, Piotrowski J, Murty VL, Slomiany A.

Gen Pharmacol. 1995 Nov;26(7):1553-8.

PMID:
8690245
14.

Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.

Piotrowski J, Majka J, Piotrowski E, Murty VL, Gabryelewicz A, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1994 Nov;34(5):875-81.

PMID:
7535617
15.

Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.

Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL.

Gen Pharmacol. 1997 May;28(5):705-8.

PMID:
9184806
16.

Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.

Piotrowski J, Morita M, Slomiany A, Slomiany BL.

Biochem Int. 1992 Jun;27(1):131-8.

PMID:
1385705
17.

Ebrotidine--a nostrum for ulcer.

Grover JK, Rathi SS, Vats V.

Trop Gastroenterol. 1997 Jul-Sep;18(3):111-3. Review. No abstract available.

PMID:
9385853
18.

Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.

Konturek PC, Brzozowski T, Konturek SI, Márquez M, Torres J, Ortiz JA.

Arzneimittelforschung. 1997 Apr;47(4A):578-89. Review.

PMID:
9205769
19.
20.

Gastric mucosal apoptosis induced by ethanol: effect of antiulcer agents.

Piotrowski J, Piotrowski E, Skrodzka D, Slomiany A, Slomiany BL.

Biochem Mol Biol Int. 1997 Jun;42(2):247-54.

PMID:
9238522

Supplemental Content

Support Center